BioCentury
ARTICLE | Company News

BBI Holdings, Inverness deal

December 17, 2007 8:00 AM UTC

Diagnostic company IMA will acquire the 88% of BBI it does not already own for cash or stock. BBI shareholders may receive either £1.95 per share in IMA stock, for a total of £73.5 million ($149.3 million), or £1.85 per share in cash, for a total of £69.8 million ($141.8 million). The stock offer is a 3% premium to BBI's close of £1.89 on Dec. 10, the last trading day before the deal was announced. The cash offer is a 2% discount. ...